查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613333

皮膚絲狀菌症病藥物市場：按治療方法、產品和銷售管道- 全球預測 2025-2030 年

Dermatophytosis Treatment Market by Treatment (Combination Therapies, Oral Antifungals, Topical Antifungals), Product (Over-the-Counter (OTC) Drugs, Prescription Drugs), Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年皮膚絲狀菌症治療市場價值為126.3億美元，預計2024年將達到133.3億美元，複合年成長率為5.88%，到2030年將達到188.5億美元，預計將達到1000萬美元。

皮膚絲狀菌症病藥物是全球醫療保健市場的重要組成部分，用於治療影響皮膚、頭髮和指甲的真菌感染疾病。該市場包括各種局部和全身抗真菌藥物，以及雷射治療和新興生物技術解決方案等新穎的治療方法。這些治療的需求是由於病菌感染在世界範圍內廣泛爆發，而潮濕的環境、衛生條件差和免疫力缺乏的個體數量不斷增加等因素加劇了這種感染。這些療法的應用涵蓋非處方藥和處方箋產品，並滿足世界各地不同的消費者需求和醫療保健政策。最終用途範圍包括醫院、零售藥局和線上平台，反映了廣泛而多樣化的市場範圍。影響該市場的主要成長要素包括配方的進步、皮膚健康意識的提高以及可支配收入的增加以促進獲得醫療保健。此外，專注於提高治療效果和最大限度減少副作用的研發活動的活性化也帶來了巨大的機會。公司可以透過投資技術創新和形成策略聯盟來擴大產品系列和地理影響力來利用這些優勢。然而，抗藥性、現有治療方法的潛在副作用以及嚴格的監管環境等限制帶來了顯著的挑戰。新興市場的經濟障礙以及來自替代療法和傳統治療方法的競爭進一步限制了市場擴張。需要創新的領域包括開發生物基抗真菌劑、動態療法以及使用基因分析來提高治療精度的個人化醫療方法。市場動態是一個充滿活力的市場，其特點是快速的技術進步和不斷變化的消費者需求，凸顯了持續研究和敏捷業務策略的重要性。對於希望實現飛躍的公司來說，繼續專注於永續的、以患者為中心的治療解決方案至關重要。

主要市場統計
基準年[2023] 126.3億美元
預計年份 [2024] 133.3億美元
預測年份 [2030] 188.5億美元
複合年成長率（%） 5.88%

市場動態：快速發展的皮膚絲狀菌症藥物市場的關鍵市場洞察

供需的動態交互作用正在改變皮膚絲狀菌症病藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 香港腳在人群中的盛行率很高
    • 人們對皮膚絲狀菌症的認知不斷提高
  • 市場限制因素
    • 與產品召回相關的重大問題
  • 市場機會
    • 新型抗黴菌藥物及新劑型研究進展
    • 透過線上銷售管道擴大非處方皮膚科產品的供應
  • 市場挑戰
    • 資本集中且耗時的產品核可流程

波特五力：駕馭皮膚絲狀菌症藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解皮膚絲狀菌症藥物市場的外部影響

外部宏觀環境因素在塑造皮膚絲狀菌症治療藥物市場的表現動態中發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解皮膚絲狀菌症治療藥物市場的競爭狀況

對皮膚絲狀菌症治療藥物市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣皮皮膚絲狀菌症治療市場供應商的績效評估

FPNV定位矩陣是評估皮膚絲狀菌症治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪皮膚絲狀菌症治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對皮膚絲狀菌症治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中香港腳盛行率高
      • 人們對皮膚絲狀菌症的認知不斷提高
    • 抑制因素
      • 與產品召回相關的嚴重問題
    • 機會
      • 研究重點是新型抗真菌藥物和新製劑
      • 透過線上銷售管道增加非處方皮膚科產品的供應
    • 任務
      • 資本集中且耗時的產品核可流程
  • 市場區隔分析

第 5 章 2.1。

第 5 章 2.2.銷售管道：

  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療分類的皮膚絲狀菌症病藥物市場

  • 聯合治療
  • 口服抗真菌藥物
  • 局部抗真菌藥物
    • 霜和乳液
    • 凝膠
    • 粉末
    • 噴

第7章皮膚絲狀菌症治療藥物市場：依產品

  • 非處方藥 (OTC)
  • 處方藥

第8章皮膚絲狀菌症治療藥物市場：依銷售管道

  • 離線
    • 醫院/診所
    • 零售藥房
  • 線上

第9章北美及南美皮皮膚絲狀菌症病治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太皮皮膚絲狀菌症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲皮皮膚絲狀菌症治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 拜耳加強 Canesten 產品系列，以改善印度真菌感染疾病的治療
    • Glenmark Pharmaceuticals 與 IADVL 合作推出「Hello Skin」聊天機器人，以對抗印度的皮膚絲狀菌症
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Ipca Laboratories Ltd
  • Leeford Healthcare Ltd
  • Mylan NV
  • Novartis AG
  • Oaknet Healthcare Pvt Ltd
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Quinnova Pharmaceuticals Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.
Product Code: MRR-7A22CB0E5C75

The Dermatophytosis Treatment Market was valued at USD 12.63 billion in 2023, expected to reach USD 13.33 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 18.85 billion by 2030.

Dermatophytosis treatment is an imperative segment within the global healthcare market, addressing fungal infections affecting skin, hair, and nails. The scope of this market includes a wide range of topical and systemic antifungal medications and novel therapeutic approaches such as laser therapy and emerging biotech solutions. The necessity for these treatments stems from the widespread occurrence of dermatophytic infections globally, exacerbated by factors like humid environments, poor hygiene, and increasing rates of immunocompromised individuals. Applications of these treatments span across both over-the-counter and prescription-based products, catering to diverse consumer needs and healthcare policies worldwide. The end-use scope includes hospitals, retail pharmacies, and online platforms, reflecting a broad and versatile market reach. Key growth factors influencing this market include advancements in drug formulations, a rise in awareness about skin health, and an increase in disposable income facilitating access to healthcare. Moreover, heightened research and development activities, focused on enhancing treatment efficacy and minimizing side effects, present vital opportunities. Companies could capitalize on these by investing in innovation and forming strategic alliances to expand their product portfolio and geographical presence. However, limitations such as drug resistance, potential side effects of existing treatments, and stringent regulatory landscapes pose notable challenges. Economic barriers in developing regions further restrict market expansion, along with competition from alternative medicine and traditional remedies. Areas ripe for innovation include the development of bio-based antifungal agents, photodynamic therapy, and personalized medicine approaches using genetic profiling to enhance treatment precision. The nature of the dermatophytosis treatment market is dynamic, characterized by rapid technological advancements and evolving consumer needs, emphasizing the importance of continuous research and agile business strategies. For businesses looking to make significant strides, maintaining a focus on sustainable and patient-centric treatment solutions will be crucial.

KEY MARKET STATISTICS
Base Year [2023] USD 12.63 billion
Estimated Year [2024] USD 13.33 billion
Forecast Year [2030] USD 18.85 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant prevalence of tinea pedis among the population
    • Growing awareness about dermatophytosis disorders
  • Market Restraints
    • Considerable issues associated with product recall
  • Market Opportunities
    • Research focused on new antifungal agents and new formulations
    • Growing availability of OTC dermatological products through online sales channels
  • Market Challenges
    • Capital-intensive and time-consuming product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Dermatophytosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatophytosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatophytosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatophytosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatophytosis Treatment Market

A detailed market share analysis in the Dermatophytosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatophytosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatophytosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatophytosis Treatment Market

A strategic analysis of the Dermatophytosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatophytosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Ipca Laboratories Ltd, Leeford Healthcare Ltd, Mylan N.V., Novartis AG, Oaknet Healthcare Pvt Ltd, Perrigo Company PLC, ProFoot, Inc., Quinnova Pharmaceuticals Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Dermatophytosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Combination Therapies, Oral Antifungals, and Topical Antifungals. The Topical Antifungals is further studied across Cream & Lotion, Gel, Powder, and Spray.
  • Based on Product, market is studied across Over-the-Counter (OTC) Drugs and Prescription Drugs.
  • Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant prevalence of tinea pedis among the population
      • 5.1.1.2. Growing awareness about dermatophytosis disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Considerable issues associated with product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Research focused on new antifungal agents and new formulations
      • 5.1.3.2. Growing availability of OTC dermatological products through online sales channels
    • 5.1.4. Challenges
      • 5.1.4.1. Capital-intensive and time-consuming product approval process
  • 5.2. Market Segmentation Analysis

5.2.1. Treatment:

5.2.2. Sales Channel:

  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermatophytosis Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Combination Therapies
  • 6.3. Oral Antifungals
  • 6.4. Topical Antifungals
    • 6.4.1. Cream & Lotion
    • 6.4.2. Gel
    • 6.4.3. Powder
    • 6.4.4. Spray

7. Dermatophytosis Treatment Market, by Product

  • 7.1. Introduction
  • 7.2. Over-the-Counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. Dermatophytosis Treatment Market, by Sales Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Retail Pharmacies
  • 8.3. Online

9. Americas Dermatophytosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Dermatophytosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Dermatophytosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Bayer Elevates Fungal Infection Treatment in India with Enhanced Canesten Range
    • 12.3.2. Glenmark Pharmaceuticals Launches 'Hello Skin' Chatbot in Collaboration with IADVL to Combat Dermatophytosis in India
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aetna Inc
  • 3. Alva-Amco Pharmacal Companies, Inc
  • 4. Aurobindo Pharma Limited
  • 5. Bausch Health Companies Inc.
  • 6. Bayer AG
  • 7. Blueberry Therapeutics Ltd.
  • 8. Cipla Ltd.
  • 9. Creative Biolabs
  • 10. Dr. Reddy's Laboratories Ltd.
  • 11. GlaxoSmithKline PLC
  • 12. Glenmark Pharmaceuticals Limited
  • 13. Ipca Laboratories Ltd
  • 14. Leeford Healthcare Ltd
  • 15. Mylan N.V.
  • 16. Novartis AG
  • 17. Oaknet Healthcare Pvt Ltd
  • 18. Perrigo Company PLC
  • 19. ProFoot, Inc.
  • 20. Quinnova Pharmaceuticals Inc.
  • 21. Sebela Pharmaceuticals Holdings Inc.
  • 22. Steris Healthcare PVT Ltd
  • 23. Sun Pharmaceutical Industries Ltd.
  • 24. Taisho Pharmaceutical Co., Ltd.
  • 25. Vibcare Pharma Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. DERMATOPHYTOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DERMATOPHYTOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMATOPHYTOSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ORAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 234. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023